W. Kwan

HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms

S. Khoo, Chloe E. James, A. Owen, 2010, Pharmacogenetics and genomics.

Intracellular 'boosting' of darunavir using known transport inhibitors in primary PBMC.

S. Khoo, A. Owen, D. Back, 2009, British journal of clinical pharmacology.

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism

A. Lazzarin, G. di Perri, A. Calcagno, 2010, Pharmacogenetics and genomics.

Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes.

S. Khoo, A. Owen, D. Back, 2009, The Journal of antimicrobial chemotherapy.

Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir

Darren L. Smith, S. Khoo, A. Owen, 2010, Antimicrobial Agents and Chemotherapy.

Investigation of Interaction between Soluble Adenylyl Cyclase and p34

W. Kwan, 2010 .

Raltegravir Is a Substrate for SLC22A6: a Putative Mechanism for the Interaction between Raltegravir and Tenofovir

Darren L. Smith, S. Khoo, A. Owen, 2010, Antimicrobial Agents and Chemotherapy.